We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Donor Dendritic Cells And Donor Lymphocytes in Patients With Relapsed Hematologic Malignancies After Allogeneic Transplant

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00476177
First Posted: May 21, 2007
Last Update Posted: March 29, 2012
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborators:
Brigham and Women's Hospital
Beth Israel Deaconess Medical Center
National Cancer Institute (NCI)
Information provided by (Responsible Party):
Edwin P. Alyea, MD, Dana-Farber Cancer Institute
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: July 2009
  Primary Completion Date: August 2007 (Final data collection date for primary outcome measure)